Numan, a startup established in February 2019, is committed to tackling the health issues faced by men, with a primary focus on addressing erectile dysfunction. In a recent achievement, the company secured a noteworthy £10 million ($13 million) in Series A funding to further enhance its lineup of products and services. Leading the funding round was Novator, accompanied by notable participants such as Anthemis Exponential, Vostok New Ventures, and Colle Capital. Numan's comprehensive range of offerings encompasses diverse health services tailored specifically for men, encompassing treatments for hair loss, smoking cessation, and, of course, erectile dysfunction.
$13M • 2020 • Series A
Numan extensive range of offerings caters to various needs, including treatments for hair loss, smoking cessation, and, notably, erectile dysfunction.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!